Consorci Hospitalari de Vic   Report issue

Academic/Hospital Phase 4
Founded: Barcelona Spain (1986)

Organization Overview

First Clinical Trial
2007
NCT01921231
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Consorci Hospitalari de Vic | Consorci Hospitalari de Vic (CHV) | Dr. Pere Roura-Poch

Active Ingredients

Drugs in Phase 4 Trials (2)

levobupivacaine (chirocaine) (1 trial)

prilocaine (citanest) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hernia (Phase 4)

Hernia, Inguinal (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2